104 related articles for article (PubMed ID: 14661053)
1. Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase.
Hobbs SS; Cameron EM; Hammer RP; Le AT; Gallo RM; Blommel EN; Coffing SL; Chang H; Riese DJ
Oncogene; 2004 Jan; 23(4):883-93. PubMed ID: 14661053
[TBL] [Abstract][Full Text] [Related]
2. Phe45 of NRG2beta is critical for the affinity of NRG2beta for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2beta*.
Hobbs SS; Gallo RM; Riese DJ
Growth Factors; 2005 Dec; 23(4):273-83. PubMed ID: 16338790
[TBL] [Abstract][Full Text] [Related]
3. The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.
Wilson KJ; Mill CP; Gallo RM; Cameron EM; VanBrocklin H; Settleman J; Riese DJ
Biochem J; 2012 Apr; 443(1):133-44. PubMed ID: 22216880
[TBL] [Abstract][Full Text] [Related]
4. Inter-conversion of neuregulin2 full and partial agonists for ErbB4.
Wilson KJ; Mill CP; Cameron EM; Hobbs SS; Hammer RP; Riese DJ
Biochem Biophys Res Commun; 2007 Dec; 364(2):351-7. PubMed ID: 17945187
[TBL] [Abstract][Full Text] [Related]
5. Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities.
Penington DJ; Bryant I; Riese DJ
Cell Growth Differ; 2002 Jun; 13(6):247-56. PubMed ID: 12114214
[TBL] [Abstract][Full Text] [Related]
6. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta.
Riese DJ; Bermingham Y; van Raaij TM; Buckley S; Plowman GD; Stern DF
Oncogene; 1996 Jan; 12(2):345-53. PubMed ID: 8570211
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation.
Hobbs SS; Coffing SL; Le AT; Cameron EM; Williams EE; Andrew M; Blommel EN; Hammer RP; Chang H; Riese DJ
Oncogene; 2002 Dec; 21(55):8442-52. PubMed ID: 12466964
[TBL] [Abstract][Full Text] [Related]
8. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
Li Z; Mei Y; Liu X; Zhou M
Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases.
Carraway KL; Weber JL; Unger MJ; Ledesma J; Yu N; Gassmann M; Lai C
Nature; 1997 May; 387(6632):512-6. PubMed ID: 9168115
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase.
Elenius K; Choi CJ; Paul S; Santiestevan E; Nishi E; Klagsbrun M
Oncogene; 1999 Apr; 18(16):2607-15. PubMed ID: 10353604
[TBL] [Abstract][Full Text] [Related]
11. The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2beta and agonist-independent coupling with downstream signalling events.
Gilmore JL; Gallo RM; Riese DJ
Biochem J; 2006 May; 396(1):79-88. PubMed ID: 16445385
[TBL] [Abstract][Full Text] [Related]
12. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
[TBL] [Abstract][Full Text] [Related]
13. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
14. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.
Plowman GD; Green JM; Culouscou JM; Carlton GW; Rothwell VM; Buckley S
Nature; 1993 Dec; 366(6454):473-5. PubMed ID: 7902537
[TBL] [Abstract][Full Text] [Related]
15. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
16. Bioactive recombinant neuregulin-1, -2, and -3 expressed in Escherichia coli.
Mautino B; Dalla Costa L; Gambarotta G; Perroteau I; Fasolo A; Dati C
Protein Expr Purif; 2004 May; 35(1):25-31. PubMed ID: 15039062
[TBL] [Abstract][Full Text] [Related]
17. Ligand-independent regulation of ErbB4 receptor phosphorylation by activated Ras.
Tal-Or P; Erlich S; Porat-Shliom N; Goldshmit Y; Ben-Baruch G; Shaharabani E; Kloog Y; Pinkas-Kramarski R
J Cell Biochem; 2006 Aug; 98(6):1482-94. PubMed ID: 16518842
[TBL] [Abstract][Full Text] [Related]
18. The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells.
Naresh A; Long W; Vidal GA; Wimley WC; Marrero L; Sartor CI; Tovey S; Cooke TG; Bartlett JM; Jones FE
Cancer Res; 2006 Jun; 66(12):6412-20. PubMed ID: 16778220
[TBL] [Abstract][Full Text] [Related]
19. Unique carboxyl-terminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-alpha precursors mediate specific interactions with ErbB4 and ErbB2.
Xu X; Kelleher KF; Liao J; Creek KE; Pirisi L
Oncogene; 2000 Jun; 19(28):3172-81. PubMed ID: 10918572
[TBL] [Abstract][Full Text] [Related]
20. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
Schaefer G; Fitzpatrick VD; Sliwkowski MX
Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
